— Know what they know.
Not Investment Advice

BIOVF OTC

Swedish Orphan Biovitrum AB (publ)
1W: -10.9% 1M: -10.9% 3M: -10.6% YTD: +21.7% 1Y: +42.8% 3Y: +113.7%
$42.90
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 40 · $14.9B mcap · 181M float · 0.0000% daily turnover · Short 86% of daily vol

📊 Key Metrics

TTM
$31B
Revenue
+13.3% YoY
$1B
Net Income
-68.0% YoY
$7B
Free Cash Flow
+77.8% YoY
76.7%
Gross Margin
26.4%
Op. Margin
14.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE3.4%
ROA1.8%
ROIC17.2%

Valuation

P/E107.8
P/B3.5
EV/EBITDA0.0

Leverage

Debt/Equity0.42
Current Ratio0.88
Interest Cov.6.7x

Quality Scores

Piotroski F4/9
Altman Z—
Beneish M-2.39

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms